
via Curtin University
Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia’s second-leading cause of death.
The study, published in the prestigious PLOS Biology journal and tested on mouse models, identified that a probable cause of Alzheimer’s disease was the leakage from blood into the brain of fat-carrying particles transporting toxic proteins.
Lead investigator Curtin Health Innovation Research Institute (CHIRI) Director Professor John Mamo said his collaborative group of Australian scientists had identified the probable ‘blood-to-brain pathway’ that can lead to Alzheimer’s disease, the most prevalent form of dementia globally.
“While we previously knew that the hallmark feature of people living with Alzheimer’s disease was the progressive accumulation of toxic protein deposits within the brain called beta-amyloid, researchers did not know where the amyloid originated from, or why it deposited in the brain,” Professor Mamo said.
“Our research shows that these toxic protein deposits that form in the brains of people living with Alzheimer’s disease most likely leak into the brain from fat carrying particles in blood, called lipoproteins.
“This ‘blood-to-brain pathway’ is significant because if we can manage the levels in blood of lipoprotein-amyloid and prevent their leakage into the brain, this opens up potential new treatments to prevent Alzheimer’s disease and slow memory loss.”
Building on previous award-winning research that showed beta-amyloid is made outside the brain with lipoproteins, Professor Mamo’s team tested the ground-breaking ‘blood-to-brain pathway’ by genetically engineering mouse models to produce human amyloid-only liver that make lipoproteins.
“As we predicted, the study found that mouse models producing lipoprotein-amyloid in the liver suffered inflammation in the brain, accelerated brain cell death and memory loss,” Professor Mamo said.
“While further studies are now needed, this finding shows the abundance of these toxic protein deposits in the blood could potentially be addressed through a person’s diet and some drugs that could specifically target lipoprotein amyloid, therefore reducing their risk or slowing the progression of Alzheimer’s disease.”
Alzheimer’s WA Chairman Adjunct Professor Warren Harding said the findings may have a significant global impact for the millions of people living with Alzheimer’s disease.
“Having universities like Curtin working with the pharmaceutical industry is important if we are to tackle this devastating disease,” Mr Harding said.
“In Australia, approximately 250 people are diagnosed with dementia daily, adding to the staggering half a million Australians who are already living with dementia. Without significant medical advances like the breakthrough Professor Mamo’s team has made, it is estimated that the number of Australians living with dementia will exceed one million by 2058. This has a significant impact on families, carers and communities.”
Professor Mamo and his research team’s previous research in this area was awarded the NHMRC-Marshall and Warren Award for the most innovative and potentially transformative research.
Currently, the team is conducting a clinical trial, the Probucol in Alzheimer’s-clinical trial, which is based on previous findings that a historic cardiovascular agent lowers lipoprotein-amyloid production and supports cognitive performance in mice. The mouse models used for this research were developed together with Ozgene.
Original Article: New Curtin research identifies likely cause of Alzheimer’s disease
More from: Curtin University
The Latest on: Alzheimer’s
- Menopause symptoms: Brain fog or Alzheimer’s symptoms? Doctor clears up the confusionon May 27, 2022 at 8:00 pm
A DOCTOR has warned chemical changes in the body during menopause can be "connected" to the onset of Alzheimer's disease but assures women that most symptoms of memory loss will be unrelated to the ...
- Medicare premium increase from Alzheimer’s drug to be lowered next yearon May 27, 2022 at 1:30 pm
Health and Human Services Secretary Xavier Becerra announced on Friday that Medicare premiums would be adjusted for 2023 following a report that found the cost of including a new Alzheimer’s ...
- Max Lugavere on Alzheimer’s disease: Your diet and lifestyle ‘pull the trigger’on May 27, 2022 at 11:57 am
Nutrition expert explains how Alzheimer’s disease personally impacted him as he rallies for furthering research development and medical studies on ‘Tucker Carlson Tonight.’ ...
- Couple says finding support helped through Alzheimer's journey. Here's how to copeon May 27, 2022 at 6:53 am
Caring for a family member diagnosed with Alzheimer's can be physically, mentally and emotionally challenging, but for one couple in Anne Arundel County, finding support has been key to battling the ...
- Researchers link sugar-studded protein to Alzheimer's diseaseon May 27, 2022 at 4:10 am
In a bit of "reverse engineering" research using brain tissues from five people who died with Alzheimer's disease, Johns Hopkins Medicine researchers say they discovered that a special sugar molecule ...
- Gene Finding Links Vascular Disease to Alzheimer'son May 27, 2022 at 2:05 am
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease. The conditions can all ...
- Researchers may have found the missing link between Alzheimer's and vascular diseaseon May 25, 2022 at 1:54 pm
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer's disease.
- If You Have This Gene, Be Worried About Alzheimer'son May 20, 2022 at 5:15 am
Americans are living with Alzheimer's disease (the most common form of dementia) as of 2020, according to the CDC. "It's important for those over 65 to be aware of the early signs and symptoms of ...
- Holistic Program May Help People With Alzheimer's, Dementiaon May 19, 2022 at 9:08 am
Those who enroll are assigned to groups that meet virtually twice a week for 1-hour sessions. The sessions are livestreamed, so participants are engaging with each other and with the instructors in ...
via Bing News
The Latest on: Alzheimer’s
via Google News
Add Comment